CSIMarket
 


Casi Pharmaceuticals inc   (CASI)
Other Ticker:  
 

Casi Pharmaceuticals Inc 's Total Debt to Equity

CASI's quarterly Total Debt to Equity and Total Debt, Equity growth




CASI Total Debt to Equity (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change -28.75 % -29.39 % -25.03 % 3.63 % -5.38 %
Y / Y Total Debt Change 176.75 % -35.34 % - - -
Total Debt to Equity MRQ 0.05 0.01 - - 0.01
Overall Ranking # # # # #
Seq. Equity Change -7.82 % -10.73 % -11.26 % -2.43 % -8.64 %
Seq. Total Debt Change 199.7 % - - - -29.97 %



Total Debt to Equity third quarter 2022 Comment
Due to net new borrowings of 199.7%, Total Debt to Equity detoriated to 0.05, above company's average Total Debt to Equity.

Within Biotechnology & Pharmaceuticals industry Casi Pharmaceuticals inc achieved lowest Total Debt to Equity. While total ranking remained unchanged compare to previous quarter at no. .

Explain Debt to Equity Ratio?
Where is CASI most successful ?
Total Debt to Equity CASI on the trailing twelve month basis
Total Debt to Equity third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #


Total Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
Casi Pharmaceuticals Inc 's Equity $ 62 Millions Visit CASI's Balance sheet
Casi Pharmaceuticals Inc 's Total Debt $ 3 Millions Visit CASI's Balance sheet
Source of CASI's Sales Visit CASI's Sales by Geography


Cumulative Casi Pharmaceuticals Inc 's Total Debt to Equity

CASI's Total Debt to Equity for the trailling 12 Months

CASI Total Debt to Equity

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth -28.75 % -29.39 % -25.03 % 3.63 % -5.38 %
Y / Y Total Debt TTM Growth 176.75 % -35.34 % - - -
Total Debt to Equity TTM 0.01 0.01 0.01 0.01 0.01
Total Ranking TTM # 519 # 398 # 397 # 583 # 455
Seq. Equity TTM Growth -7.82 % -10.73 % -11.26 % -2.43 % -8.64 %
Seq. Total Debt TTM Growth 199.7 % - - - -29.97 %


TTM Total Debt to Equity Comment
On the trailing twelve months basis Despite of the net new borrowings of 199.7% Casi Pharmaceuticals Inc managed to unchange Total Debt to Equity in III. Quarter to 0.01, below Casi Pharmaceuticals Inc 's average Total Debt to Equity.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry 20 other companies have achieved lower Total Debt to Equity than Casi Pharmaceuticals Inc . While total ranking remained unchanged compare to previous quarter at no. 519.

Explain Debt to Equity Ratio?
Where is CASI most successful ?
Total Debt to Equity CASI on the trailing twelve month basis

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 21
Healthcare Sector # 121
Within the Market # 519


TTM Total Debt to Equity Statistics
High Average Low
0.01 0.01 0
(Jun 30 2019)   (Dec 31 2020)




Companies with similar Total Debt to Equity in the quarter ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Total Debt to EquitySep 30 2022 MRQ Total DebtSep 30 2022 MRQ Equity
Enovis Corp  0.13 $ 449.223  Millions$ 3,408.202  Millions
Berkeley Lights Inc   0.13 $ 19.810  Millions$ 158.183  Millions
Finch Therapeutics Group Inc   0.12 $ 14.636  Millions$ 120.866  Millions
Neurocrine Biosciences Inc   0.11 $ 169.200  Millions$ 1,544.600  Millions
Edwards Lifesciences Corporation  0.10 $ 596.200  Millions$ 6,217.800  Millions
Tarsus Pharmaceuticals Inc   0.10 $ 19.356  Millions$ 202.627  Millions
Sutro Biopharma Inc   0.08 $ 19.283  Millions$ 229.726  Millions
Orion Energy Systems Inc   0.08 $ 5.016  Millions$ 60.975  Millions
Casi Pharmaceuticals inc   0.05 $ 3.000  Millions$ 61.711  Millions
Inmune Bio Inc   0.04 $ 2.500  Millions$ 63.706  Millions
Singular Genomics Systems Inc   0.04 $ 10.026  Millions$ 276.925  Millions
Windtree Therapeutics Inc  0.04 $ 0.629  Millions$ 17.420  Millions
C4 Therapeutics Inc   0.04 $ 11.302  Millions$ 318.179  Millions
Century Therapeutics inc   0.03 $ 10.172  Millions$ 330.205  Millions
Precipio inc   0.03 $ 0.508  Millions$ 18.254  Millions
Ainos Inc   0.02 $ 0.884  Millions$ 36.426  Millions
Ocugen Inc   0.02 $ 2.265  Millions$ 95.303  Millions
Hillevax Inc   0.02 $ 4.737  Millions$ 287.193  Millions
Inhibikase Therapeutics Inc   0.01 $ 0.374  Millions$ 25.136  Millions
Nutriband Inc   0.01 $ 0.127  Millions$ 9.732  Millions

Date modified: 2022-11-16T03:23:24+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BXRO's Profile

Stock Price

BXRO's Financials

Business Description

Fundamentals

Charts & Quotes

BXRO's News

Suppliers

BXRO's Competitors

Customers & Markets

Economic Indicators

BXRO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071